Memorial Hospital Research Laboratories
The Irene Orlow Lab
Research
The Molecular Epidemiology Laboratory
Led by Dr. Irene Orlow, the Lab participates in self-initiated research and supports investigations from the Population Sciences & Clinical Research programs that involve handling and testing human specimens. For additional information on current research, publications, and presentations by the Lab and more, scroll down and click on the ‘View Lab Overview’ or ‘Current Projects’ links.
Receipt of Clinical Specimens in Main Campus’ S10
Current Studies: Follow the Lab’s communication guidelines for before/after procurement/sample dropped off with messengers or in the Lab, and cut-off times and location (Rm S-1028, in the designated red cooler). For potential exceptions contact us by phone (see ‘Get in Touch’), Microsoft Teams, or use the zzPDL_ bstbiospecimens for emailing the lab group. Drop-off cut-off times from clinic by type of specimen: Examples: * Blood requiring separation of plasma/ buffy coat/ serum. ** Urine requiring aliquoting and proper refrigeration. *** Saliva Oragene kits for genomics that contain a stabilizer. New aims/ new study? Contact Irene Orlow |
Research Projects
- The Genes, Environment and Melanoma (GEM) Study
- Other Current Projects
- Samples collection/banking
- Past Projects
Interested in developing new studies & collaborations with us?
People
Irene Orlow, MS, DSc
Attending Biologist
- Led by Dr. Irene Orlow, the Lab participates in self-initiated research and supports investigations from the Population Sciences & Clinical Research programs that involving human specimens processing, testing, and banking. For additional information on current research, publications, and presentations by the Lab, and more, scroll down and click on the ‘View Lab Overview’ or ‘Current Projects’ links.
- University of Buenos Aires, School of Pharmacy & Biochemistry (FFyB)
- [email protected]
- Email Address
- 646-608-8447
- Office Phone
Members
Lab News & Events
Accolades
Team Recognitions
-
We are delighted to share that our Intern Isam Mina has been elected for the 2026 Rhodes Trust Scholarship. Isam is studying at Princeton University and will graduate in May with a major in Molecular Biology. He continues co
-
The Genes, Environment and Melanoma Consortium turned 15! Anniversary at the Annual GEM meeting in Princeton, NJ. Sept 2025
-
Congratulations to Colin Begg for his 35 years as Chair of our Epidemiology & Biostatistics Department; and for being a pillar to the GEM study among others
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Career Opportunities
Get in Touch
-
Lab Head Email
-
Office Phone
-
Lab Phone
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Irene Orlow discloses the following relationships and financial interests:
-
Tolstoy Foundation Rehabilitation & Nursing Center
Fiduciary Role / Position
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].